1. Home
  2. KELYB vs IRWD Comparison

KELYB vs IRWD Comparison

Compare KELYB & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kelly Services Inc. Class B

KELYB

Kelly Services Inc. Class B

N/A

Current Price

$15.59

Market Cap

513.9M

ML Signal

N/A

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$3.56

Market Cap

526.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KELYB
IRWD
Founded
1946
1998
Country
United States
United States
Employees
5570
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
513.9M
526.7M
IPO Year
N/A
2009

Fundamental Metrics

Financial Performance
Metric
KELYB
IRWD
Price
$15.59
$3.56
Analyst Decision
Hold
Analyst Count
0
5
Target Price
N/A
$4.94
AVG Volume (30 Days)
16.6K
2.3M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
1.91%
N/A
EPS Growth
N/A
1400.00
EPS
N/A
0.15
Revenue
N/A
$298,276,000.00
Revenue This Year
$0.72
$57.95
Revenue Next Year
N/A
$4.39
P/E Ratio
N/A
$24.13
Revenue Growth
N/A
8.88
52 Week Low
$8.38
$0.55
52 Week High
$125.00
$5.78

Technical Indicators

Market Signals
Indicator
KELYB
IRWD
Relative Strength Index (RSI) 57.66 52.13
Support Level $11.66 $3.07
Resistance Level $21.46 $3.92
Average True Range (ATR) 1.00 0.21
MACD 0.32 0.07
Stochastic Oscillator 53.86 63.89

Price Performance

Historical Comparison
KELYB
IRWD

About KELYB Kelly Services Inc. Class B

Kelly Services Inc is a provider of workforce solutions and consulting, and staffing services to a diverse group of clients operating in the Americas, Europe, and the Asia-Pacific region across various industries. The company's reportable segments are: Enterprise Talent Management, Science, Engineering and Technology, and Education. Maximum revenue is generated from its Enterprise Talent Management segment, which delivers temporary staffing, outcome-based, and permanent placement services focused on light industrial, contact center, and office and clerical specialties in North America across various industries. It also provides talent supply chain and workforce talent solutions, including MSP, RPO, and PPO solutions to its clients. Geographically, it derives key revenue from the USA.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

Share on Social Networks: